Media
Press Releases
May 14, 2026
Legislative Discussion Draft of Next-Generation U.S. Clinical Development to Accelerate Cures
The United States has long led the world in biomedical discovery, translation into clinical research, and approvals of new cures and life-changing treatments. However, America’s clinical research enterprise has not kept pace and is fragmented and difficult to integrate into care sites. This discussion draft aims to modernize and improve the clinical trials process for faster and more accessible clinical trials in the U.S. For more information or to share a comment on Rep. Auchincloss' Legislati… Continue Reading
May 13, 2026RELEASE: Auchincloss, Warren, Harshbarger, Hawley Reintroduce Bipartisan Legislation to Rein in Pharmacy Benefit Managers (PBMs), Cut Drug Costs
FOR IMMEDIATE RELEASE Contact: Georgina.Burros@mail.house.gov (Auchincloss) RELEASE: Auchincloss, Warren, Harshbarger, Hawley Reintroduce Bipartisan Legislation to Rein in Pharmacy Benefit Managers (PBMs), Cut Drug Costs WASHINGTON, D.C. - Representatives Jake Auchincloss (D-MA) and Diana Harshbarger (R-TN), alongside Senators Elizabeth Warren (D-MA) and Josh Hawley (R-MO), reintroduced the Patients Before Monopolies (PBM) Act with expanded bipartisan support to rein in drug pricing middlemen… Continue Reading
April 21, 2026RELEASE: Congressman Auchincloss questions Secretary Kennedy on FDA whistleblower disclosures, White House fast-tracking of psychedelics
FOR IMMEDIATE RELEASE: Contact: Georgina.Burros@mail.house.gov (Auchincloss) WASHINGTON, D.C. - Today, Congressman Jake Auchincloss (D, MA-04) questioned Health and Human Services Secretary Robert F. Kennedy Jr. at a House Energy and Commerce Health Subcommittee hearing about the recent decision by the Food and Drug Administration (FDA) to fast track three approvals for psychedelics under the Commissioner’s National Priority Voucher (CNPV) program, based on a text Joe Rogan sent to President T… Continue Reading
In The News
May 05, 2026
Auchincloss Calls FDA Voucher Program ‘Illegal,’ Warns Of Political Pressure
House lawmaker Rep. Jake Auchincloss (D-MA) is raising legal and oversight concerns about the FDA Commissioner’s National Priority Voucher (CNPV) pilot program, citing multiple whistleblowers at senior levels of the agency who he says have described a “culture of fear” undermining its scientific credibility. Auchincloss, who is vocal on FDA issues, said despite defenses from FDA of its processes, the review voucher program is being used by the Trump administration to score political wins for th… Continue Reading
May 01, 2026Lawmakers Want to Change How Capitol Hill Approaches Tech Regulation
A growing coalition of lawmakers think there’s an opening to regulate social media by treating it the way they would drugs. A jury in New Mexico recently found Meta was responsible for misleading users about the dangers of its platforms. In a similar suit in California, a jury found Meta and YouTube liable for neglecting to protect users from adverse mental health outcomes, particularly for teens and children. And recent polls have shown a majority of adults and teenagers support restrictions o… Continue Reading
April 28, 2026Democrats Grill EPA Chief Over Plans to Slash Agency’s Budget
Environmental Protection Agency administrator Lee Zeldin defended the Trump administration’s plans to cut the agency’s budget by 52% against Democratic criticism during a combative hearing on Capitol Hill. Rep. Frank Pallone (D., N.J.) called the proposed cut to the fiscal 2027 budget “an insult to the American people,” while Rep. Troy Carter (D., La.) called it “a road map for gutting enforcement, slashing environmental protections and leaving communities to fend for themselves.” In response,… Continue Reading